• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.14% Nasdaq Down0.35%

    Repros Therapeutics Inc. (RPRX)

    -NasdaqCM
    7.37 Down 0.04(0.54%) 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development27,107  23,657  14,120  
    Selling General and Administrative5,437  4,818  4,827  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (32,544) (28,475) (18,947)
    Income from Continuing Operations
    Total Other Income/Expenses Net9  9  3  
    Earnings Before Interest And Taxes(32,535)(28,466)(18,944)
    Interest Expense -   -   -  
    Income Before Tax(32,535)(28,466)(18,944)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(32,535)(28,466)(18,944)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (32,535) (28,466) (18,944)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (32,535) (28,466) (18,944)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.